6 hasil untuk "David Liebner"
Menampilkan 1–6 · 0,33 detik · RSS
-
Artikel Jurnal
Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma
Solid organ malignancies have been reported in survivors of Hodgkin lymphoma treated with chemoradiation; however, to the best of our knowledge no cases of pulmonary synovial sarcoma have been documented in the literature in this cohort. We herein provide a detailed description of synovial sarcoma…
-
Artikel Jurnal
Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma
Objective. Thyroid disease has been reported among the endocrinopathies that can occur after treatment with ipilimumab. Graves’ disease, however, has been rarely reported with this medication. Here we report a case of Graves’ disease diagnosed after initiation of ipilimumab in a patient with…
-
Artikel Jurnal
Esophageal Gastrointestinal Stromal Tumor With MKRN1-BRAF Fusion: A Rare Mediastinal Case
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms typically involving the upper gastrointestinal tract. Most GISTs are driven by activating mutations in the KIT or PDGFRA genes, which are primary molecular markers for diagnosis and treatment. In addition, CD117 and DOG1…
-
Artikel Jurnal
Clinical markers of immunotherapy outcomes in advanced sarcoma
Abstract Background Despite immunotherapy’s promise in oncology, its use for sarcoma remains challenging. There are no sarcoma-specific biomarkers for immune checkpoint inhibitors (ICI). Previously, we reported our institutional experience highlighting ICI activity in 29 patients with sarcoma. In…
-
Artikel Jurnal
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes
Abstract Given their rarity and diversity, a fundamental understanding of the genomic underpinnings for many sarcoma subtypes is still lacking. To better define the molecular landscape of this group of diseases, we perform matched whole exome sequencing and RNA sequencing on a cohort of 1340…